Pharmacally
Gene Editing
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Gene Editing
Regulatory & Health PolicyFDA Outlines Single-BLA Framework for Rare Disease Gene EditingFDA has proposed a framework allowing multiple patient-specific genome-editing variants to be covered under a single biologics license application (BLA), subject to defined safety and evidence requirements.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.